Omega Protein Corp (OME): Wynnefield Capital Continues to Decrease Its Stake

Page 2 of 14

Page 2 of 14 – SEC Filing

CUSIP No. 68210P107 13D/A Page 2 of 14
1

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Wynnefield Partners Small Cap Value, L.P. 13-3688497

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ¨

(b) x

3

SEC USE ONLY

4

SOURCE OF FUNDS*

WC

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)

 ¨

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

345,566                   (See Item 5)

8

SHARED VOTING POWER

0                              (See Item 5)

9

SOLE DISPOSITIVE POWER

345,566                    (See Item 5)

10

SHARED DISPOSITIVE POWER

0                               (See Item 5)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

345,566               (See Item 5)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*

 ¨

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.5%

14

TYPE OF REPORTING PERSON*

PN

Follow Omega Protein Corp (NYSE:OME)



Page 2 of 14